DK3052194T3 - Veterinær fremgangsmåde til fremkaldelse af opkastning - Google Patents
Veterinær fremgangsmåde til fremkaldelse af opkastning Download PDFInfo
- Publication number
- DK3052194T3 DK3052194T3 DK14792846.9T DK14792846T DK3052194T3 DK 3052194 T3 DK3052194 T3 DK 3052194T3 DK 14792846 T DK14792846 T DK 14792846T DK 3052194 T3 DK3052194 T3 DK 3052194T3
- Authority
- DK
- Denmark
- Prior art keywords
- inducing vomiting
- veterinary procedure
- veterinary
- procedure
- vomiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361884924P | 2013-09-30 | 2013-09-30 | |
| PCT/FI2014/000022 WO2015044504A1 (en) | 2013-09-30 | 2014-09-29 | A veterinary method for inducing emesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3052194T3 true DK3052194T3 (da) | 2021-07-26 |
Family
ID=51845431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14792846.9T DK3052194T3 (da) | 2013-09-30 | 2014-09-29 | Veterinær fremgangsmåde til fremkaldelse af opkastning |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10092510B2 (da) |
| EP (1) | EP3052194B1 (da) |
| JP (1) | JP6382993B2 (da) |
| KR (1) | KR102277168B1 (da) |
| CN (1) | CN105592889B (da) |
| AU (1) | AU2014326576B2 (da) |
| BR (1) | BR112016007057B1 (da) |
| CA (1) | CA2922913C (da) |
| DK (1) | DK3052194T3 (da) |
| ES (1) | ES2878146T3 (da) |
| HR (1) | HRP20211308T1 (da) |
| HU (1) | HUE056109T2 (da) |
| LT (1) | LT3052194T (da) |
| MX (1) | MX370302B (da) |
| NZ (1) | NZ717434A (da) |
| PL (1) | PL3052194T3 (da) |
| PT (1) | PT3052194T (da) |
| RU (1) | RU2693492C2 (da) |
| SI (1) | SI3052194T1 (da) |
| WO (1) | WO2015044504A1 (da) |
| ZA (1) | ZA201601468B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3737378B1 (en) | 2018-01-12 | 2023-04-19 | Orion Corporation | Palonosetron eye drops for the treatment or prevention of nausea and vomiting |
| BR112022015340A2 (pt) | 2020-02-03 | 2022-09-27 | Orion Corp | Composições farmacêuticas estáveis de ropinirol |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1336490C (en) * | 1988-06-03 | 1995-08-01 | Paul Michael Iuvone | Pharmacological treatment of ocular development |
| FR2661832A1 (fr) * | 1990-05-11 | 1991-11-15 | Corbiere Jerome | Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues. |
| JP2008308489A (ja) * | 2007-05-11 | 2008-12-25 | Santen Pharmaceut Co Ltd | ロピニロール又はその塩を有効成分として含有する後眼部疾患の予防又は治療剤 |
-
2014
- 2014-09-29 EP EP14792846.9A patent/EP3052194B1/en active Active
- 2014-09-29 AU AU2014326576A patent/AU2014326576B2/en active Active
- 2014-09-29 CA CA2922913A patent/CA2922913C/en active Active
- 2014-09-29 RU RU2016116810A patent/RU2693492C2/ru active
- 2014-09-29 HU HUE14792846A patent/HUE056109T2/hu unknown
- 2014-09-29 SI SI201431851T patent/SI3052194T1/sl unknown
- 2014-09-29 NZ NZ717434A patent/NZ717434A/en unknown
- 2014-09-29 WO PCT/FI2014/000022 patent/WO2015044504A1/en active Application Filing
- 2014-09-29 MX MX2016003904A patent/MX370302B/es active IP Right Grant
- 2014-09-29 PT PT147928469T patent/PT3052194T/pt unknown
- 2014-09-29 LT LTEPPCT/FI2014/000022T patent/LT3052194T/lt unknown
- 2014-09-29 DK DK14792846.9T patent/DK3052194T3/da active
- 2014-09-29 JP JP2016544775A patent/JP6382993B2/ja active Active
- 2014-09-29 KR KR1020167011155A patent/KR102277168B1/ko active IP Right Grant
- 2014-09-29 PL PL14792846T patent/PL3052194T3/pl unknown
- 2014-09-29 BR BR112016007057-7A patent/BR112016007057B1/pt active IP Right Grant
- 2014-09-29 US US15/025,681 patent/US10092510B2/en active Active
- 2014-09-29 ES ES14792846T patent/ES2878146T3/es active Active
- 2014-09-29 CN CN201480053636.0A patent/CN105592889B/zh active Active
-
2016
- 2016-03-03 ZA ZA2016/01468A patent/ZA201601468B/en unknown
-
2021
- 2021-08-13 HR HRP20211308TT patent/HRP20211308T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014326576B2 (en) | 2019-03-14 |
| RU2016116810A (ru) | 2017-11-10 |
| CN105592889A (zh) | 2016-05-18 |
| MX370302B (es) | 2019-12-09 |
| NZ717434A (en) | 2019-03-29 |
| RU2693492C2 (ru) | 2019-07-03 |
| US20160206555A1 (en) | 2016-07-21 |
| CN105592889B (zh) | 2019-06-21 |
| HRP20211308T1 (hr) | 2021-11-26 |
| CA2922913A1 (en) | 2015-04-02 |
| US10092510B2 (en) | 2018-10-09 |
| AU2014326576A1 (en) | 2016-03-17 |
| PT3052194T (pt) | 2021-07-06 |
| PL3052194T3 (pl) | 2021-12-13 |
| CA2922913C (en) | 2021-09-07 |
| HUE056109T2 (hu) | 2022-01-28 |
| BR112016007057A2 (pt) | 2017-08-01 |
| RU2016116810A3 (da) | 2018-07-02 |
| EP3052194A1 (en) | 2016-08-10 |
| WO2015044504A1 (en) | 2015-04-02 |
| SI3052194T1 (sl) | 2021-09-30 |
| ZA201601468B (en) | 2017-06-28 |
| LT3052194T (lt) | 2021-07-12 |
| EP3052194B1 (en) | 2021-06-16 |
| ES2878146T3 (es) | 2021-11-18 |
| JP2016531940A (ja) | 2016-10-13 |
| BR112016007057B1 (pt) | 2023-04-11 |
| MX2016003904A (es) | 2016-06-17 |
| KR102277168B1 (ko) | 2021-07-15 |
| KR20160062130A (ko) | 2016-06-01 |
| JP6382993B2 (ja) | 2018-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3083540T3 (da) | Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner | |
| DK2996556T3 (da) | System til billedstyret procedure | |
| DK3079836T3 (da) | Fremgangsmåder til fremstilling af effektlag | |
| DK3300610T3 (da) | Fremgangsmåde til fraktionering af opløselige ærter | |
| DK3545906T3 (da) | Indretning til udskiftning af hjerteklap | |
| DK3401372T3 (da) | Blæk til laserbilleddannelse | |
| DK2953972T3 (da) | Fremgangsmåde til udvælgelse af antistoffer mod bcma | |
| DK3006568T3 (da) | Fremgangsmåde til fremstilling af tagatose | |
| DK3544364T3 (da) | Indretninger til radioforbindelser | |
| DK3013544T3 (da) | Fremgangsmåde til betonfremstilling | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| DK3087371T3 (da) | Fremgangsmåde til klassificering af frø | |
| DK2865469T3 (da) | Spændeindretning | |
| DK3079743T3 (da) | Anordning | |
| DK2992104T3 (da) | Fremgangsmåde til ekspression | |
| ES1089856Y (es) | Dispositivos de sujecion | |
| DK3369724T3 (da) | Fremgangsmåde til fremstilling af iopamidol | |
| DK2983680T3 (da) | Forbedring af organer til transplantation | |
| DK3065790T3 (da) | Fremgangsmåder til fjernelse af alpha-galactose | |
| DK2999544T3 (da) | Substansfragmenterende indretning | |
| UA27558S (uk) | Лінза | |
| DK3052931T3 (da) | Fremgangsmåde til overførsel af opslæmning | |
| DK2837678T3 (da) | Fremgangsmåde til forbedret afsmeltning | |
| DK3148993T3 (da) | Fremgangsmåde til fremstilling af thiazolderivater | |
| DK3149422T3 (da) | Anordning til fremstilling af cementklinker |